Review Finds CABG Bests PCI in End-Stage Renal Disease

This article originally appeared here.
Share this content:
Review Finds CABG Bests PCI in End-Stage Renal Disease
Review Finds CABG Bests PCI in End-Stage Renal Disease

THURSDAY, May 5, 2016 (HealthDay News) -- For patients with end-stage renal disease (ESRD) referred for coronary revascularization, coronary artery bypass grafting (CABG) is associated with a small decrease in long-term mortality compared with percutaneous coronary intervention (PCI), according to a review published in the May 15 issue of The American Journal of Cardiology.

Ashok Krishnaswami, M.D., from the Kaiser Permanente San Jose Medical Center in California, and colleagues performed an updated systematic review and meta-analysis of observational studies comparing CABG and PCI in patients with ESRD for the primary outcome of long-term mortality. Observational studies published after 2011 were included to ensure overlap with previous studies; seven new studies were included for a total of 23. The median sample size was 125 patients (25 to 15,784), with large variation seen in adjustment for covariate risk.

The researchers found that CABG correlated with a small reduction in mortality (relative risk, 0.92), with considerable heterogeneity (I² = 48.6 percent). The summary estimate trending toward survival benefit of CABG was confirmed in subgroup analysis categorized by year of study initiation; in addition, after 2004 there was a considerable decrease in heterogeneity (I² = 0 percent).

"The generalizability of the finding to all patients with ESRD referred for coronary revascularization is limited because of a lack of known indications for coronary revascularization, substantial variation in covariate risk adjustment, and lack of randomized clinical trial data," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

NTproBNP Levels Are Significantly Lower in Blacks

NTproBNP Levels Are Significantly Lower in Blacks

Higher NTproBNP levels linked to increased risk of death; this association did not differ by race

Data May Weigh on Pros/Cons of Expanded Care Optometry

Data May Weigh on Pros/Cons of Expanded Care ...

Majority of residents in Kentucky, Oklahoma, New Mexico live within 30 minutes of ophthalmologist

Gaps Seen Between Hearing Loss, Receipt of Medical Evaluation, Tx

Gaps Seen Between Hearing Loss, Receipt of Medical ...

About 20.6 percent of those with hearing less than excellent/good had visited doctor for hearing issues

is free, fast, and customized just for you!

Already a member?

Sign In Now »